BRO

Brown & Brown, Inc. BRO is expected to register an improvement in both top and bottom lines when it reports third-quarter 2026 2026 results on Oct. 26, after the closing bell. The Zacks Consensus Estimate for BRO's third-quarter revenues is pegged at $1.76 billion, indicating 9.8% growth from the year-ago reported figure. The consensus estimate for the bottom line is pegged at $1.08 per share. The Zacks Consensus Estimate for BRO's third-quarter earnings has moved south by 0.9% in the past 30 days. The estimate suggests a year-over-year increase of 2.9%. Our proven model predicts an earnings beat for Brown & Brown this time. This is because the stock has the right combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold), which increases the chances of an earnings beat. Earnings ESP: Brown & Brown has an Earnings ESP of +1.62% at present. This is because the Most Accurate Estimate of $1.10 is pegged higher than the Zacks Consensus Estimate of $1.08. You can uncover the best stocks to buy or sell before they're reported with our Earnings ESP Filter. Brown & Brown, Inc. price-eps-surprise | Brown & Brown, Inc. Quote Zacks Rank: Brown & Brown currently carries a Zacks Rank #3. You can see the complete list of today's Zacks #1 Rank stocks here. Core commissions and fees are likely to have benefited from net new and renewal business, and acquisitions. Profit-sharing contingent commissions are expected to have benefited from improved underwriting results at insurance carrier partners, higher premium volumes and favorable carrier contract terms. Recent acquisitions also support growth in contingent commissions. Net investment income is expected to benefit from interest income earned from the proceeds of the company's follow-on common stock offering. The Zacks Consensus Estimate is pegged at $23.5 million. Organic revenues in the Retail segment are likely to have benefited from net new business written over the preceding 12 months and growth in renewals of existing customers. However, slowing rate increases and rate decreases in certain coverage lines could moderate growth. Net new business and exposure unit increases are expected to have aided organic revenues in the Wholesale Brokerage segment. Expenses are expected to have increased due to higher employee compensation and benefits, other operating expenses, amortization and depreciation, reflecting the impact of acquisitions and investments in business capabilities. Here are three other insurance stocks that you may want to consider, as our model shows that these, too, have the right combination of elements to post an earnings beat: Cincinnati Financial Corporation CINF has an Earnings ESP of +2.51% and a Zacks Rank #2 at present. The Zacks Consensus Estimate for third-quarter 2026 earnings is pegged at $1.99, indicating a year-over-year decrease of 30.2%. CINF's earnings beat estimates in three of the last four reported quarters and missed in one. The Allstate Corporation ALL has an Earnings ESP of +5.25% and a Zacks Rank #3 at present. The Zacks Consensus Estimate for third-quarter 2026 earnings is pegged at $7.03, indicating a year-over-year decrease of 37.1%. ALL's earnings beat estimates in each of the last four reported quarters. Arch Capital Group Ltd. ACGL has an Earnings ESP of +11.70% and a Zacks Rank #3 at present. The Zacks Consensus Estimate for third-quarter 2026 earnings is pegged at $2.05 per share, indicating a year-over-year decrease of 26%. ACGL's earnings beat estimates in each of the last four reported quarters. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Brown & Brown, Inc. (BRO) : Free Stock Analysis Report Cincinnati Financial Corporation (CINF) : Free Stock Analysis Report The Allstate Corporation (ALL) : Free Stock Analysis Report Arch Capital Group Ltd. (ACGL) : Free Stock Analysis Report This article originally published on Zacks Investment Research (zacks.com). Zacks Investment Research

Aon (AON) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2026. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price. The earnings report, which is expected to be released on October 28, might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower. While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise. This insurance brokerage is expected to post quarterly earnings of $3.34 per share in its upcoming report, which represents a year-over-year change of +9.5%. Revenues are expected to be $4.08 billion, up 2% from the year-ago quarter. The consensus EPS estimate for the quarter has been revised 3.06% lower over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period. Investors should keep in mind that an aggregate change may not always reflect the direction of estimate revisions by each of the covering analysts. Price, Consensus and EPS Surprise Estimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. This insight is at the core of our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction). The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier. Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only. A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP. Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell). For Aon, the Most Accurate Estimate is lower than the Zacks Consensus Estimate, suggesting that analysts have recently become bearish on the company's earnings prospects. This has resulted in an Earnings ESP of -0.80%. On the other hand, the stock currently carries a Zacks Rank of #4. So, this combination makes it difficult to conclusively predict that Aon will beat the consensus EPS estimate. While calculating estimates for a company's future earnings, analysts often consider to what extent it has been able to match past consensus estimates. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number. For the last reported quarter, it was expected that Aon would post earnings of $3.77 per share when it actually produced earnings of $3.81, delivering a surprise of +1.06%. Over the last four quarters, the company has beaten consensus EPS estimates four times. An earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss. That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported. Aon doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release. Brown & Brown (BRO), another stock in the Zacks Insurance - Brokerage industry, is expected to report earnings per share of $1.08 for the quarter ended September 2026. This estimate points to a year-over-year change of +2.9%. Revenues for the quarter are expected to be $1.76 billion, up 9.9% from the year-ago quarter. The consensus EPS estimate for Brown & Brown has been revised 0.1% lower over the last 30 days to the current level. However, a higher Most Accurate Estimate has resulted in an Earnings ESP of +1.62%. When combined with a Zacks Rank of #3 (Hold), this Earnings ESP indicates that Brown & Brown will most likely beat the consensus EPS estimate. Over the last four quarters, the company surpassed consensus EPS estimates three times. Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Aon plc (AON) : Free Stock Analysis Report Brown & Brown, Inc. (BRO) : Free Stock Analysis Report This article originally published on Zacks Investment Research (zacks.com). Zacks Investment Research

The market expects Brown & Brown (BRO) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2026. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates. The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on October 26. On the other hand, if they miss, the stock may move lower. While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise. This insurance company is expected to post quarterly earnings of $1.08 per share in its upcoming report, which represents a year-over-year change of +2.9%. Revenues are expected to be $1.76 billion, up 9.9% from the year-ago quarter. The consensus EPS estimate for the quarter has been revised 0.06% lower over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period. Investors should keep in mind that an aggregate change may not always reflect the direction of estimate revisions by each of the covering analysts. Price, Consensus and EPS Surprise Estimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. This insight is at the core of our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction). The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier. Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only. A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP. Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell). For Brown & Brown, the Most Accurate Estimate is higher than the Zacks Consensus Estimate, suggesting that analysts have recently become bullish on the company's earnings prospects. This has resulted in an Earnings ESP of +1.62%. On the other hand, the stock currently carries a Zacks Rank of #3. So, this combination indicates that Brown & Brown will most likely beat the consensus EPS estimate. Analysts often consider to what extent a company has been able to match consensus estimates in the past while calculating their estimates for its future earnings. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number. For the last reported quarter, it was expected that Brown & Brown would post earnings of $1.08 per share when it actually produced earnings of $1.07, delivering a surprise of -0.93%. Over the last four quarters, the company has beaten consensus EPS estimates three times. An earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss. That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported. Brown & Brown appears a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release. Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Brown & Brown, Inc. (BRO) : Free Stock Analysis Report This article originally published on Zacks Investment Research (zacks.com). Zacks Investment Research

Daytona Beach, Florida-based Brown & Brown, Inc. (BRO) markets and sells insurance products and services in the United States and internationally. Valued at a market cap of $20.4 billion, the company operates through Retail and Specialty Distribution segments and provides property and casualty insurance, employee benefits insurance, personal insurance, specialty insurance, and more. BRO is expected to release its Q3 2026 earnings on Monday, October 26, after the market closes. Ahead of the event, analysts expect the company's EPS to be $1.08 on a diluted basis, up 2.9% from $1.05 in the year-ago quarter. The company has exceeded Wall Street's EPS estimates in three of its last four quarters, while missing on one occasion. - Late Billionaire Charlie Munger Told Value Investors to 'Get Used To Making Less' Because They All Want 'A Diminished Bunch Of Opportunities' but Warren Buffett Disagrees - Why It's Time to Load Up on Qualcomm Stock - 100,000 Reasons to Buy Oracle Stock - Tired of missing midday reversals? The FREE Barchart Brief newsletter keeps you in the know. Sign up now! For fiscal 2026, analysts project the company's EPS to be $4.50, up 5.6% from $4.26 in fiscal 2025. Moreover, its EPS is expected to rise by roughly 8.2% year over year (YoY) to $4.87 in fiscal 2027. BRO stock has fallen 35.4% over the past 52 weeks, lagging behind the S&P 500 Index's ($SPX) 16% rise and the State Street Financial Select Sector SPDR ETF's (XLF) marginal rise during the same time frame. On July 28, BRO stock rose 5.7% after it released Q2 2026 earnings. The company's revenue for the period rose by a robust 30.4% from the prior year's quarter to $1.7 billion, but missed the consensus estimates. Moreover, its adjusted EPS came in at $1.07, which also missed the consensus estimates. Investors looked past the revenue shortfall and focused on strong year-over-year growth and the company's ability to meet profit targets, demonstrating the sustained demand for its services and effective management of its cost structure. Analysts are unsure about BRO, with the stock having a "Hold" rating overall. Among the 22 analysts covering the stock, three are recommending a "Strong Buy," one recommends a "Moderate Buy," 17 suggest a "Hold," and one suggests a "Moderate Sell" for the stock. BRO's average analyst price target is $74.35, indicating an upside of 21.9% from the current levels. On the date of publication, Aritra Gangopadhyay did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Barchart.com

DAYTONA BEACH, Fla., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Brown & Brown, Inc. (NYSE: BRO) announces it will release its 2026 third-quarter earnings on Monday, October 26, 2026, after the close of the market. On Tuesday, October 27, 2026, J. Powell Brown, Brown & Brown's president and chief executive officer, and R. Andrew Watts, Brown & Brown's executive vice president and chief financial officer, will host an investor update conference call concerning Brown & Brown's third-quarter 2026 financial results. You are invited to listen to the call, which will be broadcast live on Brown & Brown's website at 8:00 a.m. EDT. Simply log on to www.bbrown.com and click on "Investor Relations" and then "Calendar of Events." If you are unable to listen during the live webcast, audio from the conference call will be archived on Brown & Brown's website, www.bbrown.com, for 14 days after the live broadcast. To access the website replay, go to "Investor Relations" and click on "Calendar of Events." About Brown & Brown, Inc. Brown & Brown, Inc. (NYSE: BRO) is a leading insurance brokerage firm delivering comprehensive and customized insurance solutions and specialization since 1939. With a global presence spanning 700+ locations and a team of approximately 23,000 professionals, we are dedicated to delivering scalable, innovative strategies for our customers at every step of their growth journey. Learn more at BBrown.com. This press release may contain certain statements relating to future results, which are forward-looking statements, including those associated with the timing of the release of our third-quarter results. These statements are not historical facts but instead represent only the current belief of Brown & Brown, Inc. and its subsidiaries (collectively the "Company") regarding future events, many of which, by their nature, are inherently uncertain and outside of the Company's control. It is possible that actual events may differ from anticipated events contemplated by these forward-looking statements and that we may release our third-quarter results at a later date as a result. Further information concerning the Company and its business, including factors that potentially could materially affect the Company's release of its financial results, is contained in the Company's filings with the Securities and Exchange Commission. All forward-looking statements made herein are made only as of the date of this release, and the Company does not undertake any obligation to publicly update or correct any forward-looking statements to reflect events or circumstances that subsequently occur or of which the Company hereafter becomes aware. For more information: R. Andrew Watts Chief Financial Officer (386) 239-5770

It has been about a month since the last earnings report for Aon (AON). Shares have lost about 4.6% in that time frame, underperforming the S&P 500. But investors have to be wondering, will the recent negative trend continue leading up to its next earnings release, or is Aon due for a breakout? Well, first let's take a quick look at its latest earnings report in order to get a better handle on the recent drivers for Aon plc before we dive into how investors and analysts have reacted as of late. Aon Q2 Earnings Beat Estimates on New Business Wins, Strong Retention Aon reported second-quarter 2026 adjusted earnings of $3.81 per share, which surpassed the Zacks Consensus Estimate by 1.1%. The bottom line advanced 9% year over year. Total revenues of $4.2 billion grew 2% year over year.  The top line missed the consensus mark by 0.4%. Organic revenue growth was 5%. The quarterly results were supported by strong organic revenue growth, healthy client retention, operating margin expansion and disciplined execution. Solid performance across the Commercial Risk, Reinsurance and Health Solutions businesses was partly offset by weakness in Wealth Solutions. Total operating expenses inched up 1% year over year to $3.3 billion due to higher expenses related to organic revenue growth, investments in long-term growth and unfavorable foreign currency translation. This was partly offset by lower expenses associated with the sale of NFP Wealth. The metric was in line with our estimate. Adjusted operating income amounted to $1.2 billion, up 5% year over year and in line with our estimate. The metric benefited from organic revenue growth, scale improvements in scale improvements in Aon Business Services (ABS) and net restructuring savings, partially offset by growth investments. Adjusted operating margin improved 70 basis points year over year to 28.9%. Commercial Risk Solutions: Organic revenues rose 5% year over year in the second quarter on the back of new business and strong retention rates across North America and EMEA. Revenues in this solution line advanced 5% year over year to $2.3 billion, in line with the Zacks Consensus Estimate. Reinsurance Solutions: Organic revenues grew 5% year over year, driven by increased treaty placements, new business wins and strong client retention, along with growth in facultative placements. Revenues amounted to $711 million, which improved 3% year over year but missed the consensus mark by 1%. Health Solutions: Organic revenues inched up 5% year over year as a result of new business growth, strong retention rates and positive market impact. The solution line’s revenues increased 6% year over year to $818 million, which beat the Zacks Consensus Estimate by 0.4%. Wealth Solutions: Organic revenue growth of 5% was driven by expansion in Retirement and continued demand for advisory services in the UK and EMEA amid ongoing regulatory changes. Revenues totaled $426 million, down 18% year over year. The metric lagged the consensus mark by 3.2%. Aon exited the second quarter with cash and cash equivalents of $1.1 billion, which declined 11.1% from the 2025-end level. Total assets of $53.3 billion increased 5% from the 2025-end figure. Long-term debt amounted to $12.9 billion, down 11.7% from the figure as of Dec. 31, 2025. Short-term debt and the current portion of long-term debt totaled $2 billion. Aon generated cash flow from operations of $556 million, which decreased 30% year over year. Adjusted free cash flow decreased 34% year over year to $483 million. Aon bought back 1.9 million Class A ordinary shares for roughly $600 million in the second quarter of 2026. It also returned $175 million to shareholders through dividends. As of June 30, 2026, the company had approximately $7.7 billion remaining under its share repurchase authorization. Aon expects mid-single-digit or higher organic revenue growth in 2026. The company anticipates adjusted operating margin expansion of 70-80 basis points. It projects strong growth in adjusted EPS for the year. Free cash flow is likely to grow at a double-digit rate, while the tax rate is expected to be in the 19.5-20.5% range. In the past month, investors have witnessed a downward trend in estimates review. At this time, Aon has a poor Growth Score of F, however its Momentum Score is doing a lot better with a C. Charting a somewhat similar path, the stock was allocated a score of D on the value side, putting it in the bottom 40% for this investment strategy. Overall, the stock has an aggregate VGM Score of F. If you aren't focused on one strategy, this score is the one you should be interested in. Estimates have been broadly trending downward for the stock, and the magnitude of these revisions indicates a downward shift. Interestingly, Aon has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months. Aon belongs to the Zacks Insurance - Brokerage industry. Another stock from the same industry, Brown & Brown (BRO), has gained 0.7% over the past month. More than a month has passed since the company reported results for the quarter ended June 2026. Brown & Brown reported revenues of $1.68 billion in the last reported quarter, representing a year-over-year change of +30.4%. EPS of $1.07 for the same period compares with $1.03 a year ago. For the current quarter, Brown & Brown is expected to post earnings of $1.09 per share, indicating a change of +3.8% from the year-ago quarter. The Zacks Consensus Estimate has changed +0.8% over the last 30 days. The overall direction and magnitude of estimate revisions translate into a Zacks Rank #3 (Hold) for Brown & Brown. Also, the stock has a VGM Score of F. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Aon plc (AON) : Free Stock Analysis Report Brown & Brown, Inc. (BRO) : Free Stock Analysis Report This article originally published on Zacks Investment Research (zacks.com). Zacks Investment Research

A month has gone by since the last earnings report for Brown & Brown (BRO). Shares have lost about 0.4% in that time frame, underperforming the S&P 500. But investors have to be wondering, will the recent negative trend continue leading up to its next earnings release, or is Brown & Brown due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important catalysts. Brown & Brown Q2 Earnings Miss Estimates on Weak Organic GrowthBrown & Brown, Inc.’s second-quarter 2026 adjusted earnings of $1.07 per share missed the Zacks Consensus Estimate by 0.9%. The bottom line increased 3.9% year over year. Revenues of $1.67 billion missed the consensus mark by 2.9% but increased 30.4% year over year. Acquisition activity supported the top line, while organic revenues declined 0.7%. Commissions and fees rose 32.4% to $1.65 billion, while investment and other income declined to $22 million from $36 million. Adjusted EBITDAC margin contracted 100 basis points to 35.7%. Adjusted net income attributable to the company increased 18.4% to $361 million. However, a 14% increase in the diluted weighted-average share count limited per-share growth. GAAP net income rose 24.7% to $288 million, while diluted GAAP earnings increased 7.7% to 84 cents. Organic revenues decreased 0.7% to $1.18 billion. Organic revenues with contingent commissions increased 0.7% to $1.24 billion, supported by higher profit-sharing commissions from insurance carriers. Core commissions and fees increased 30.3% year over year to $1.57 billion. Investment income and other income decreased 39% year over year to $22 million. Retail revenues increased 35.9% year over year to $947 million, primarily due to acquisition activity. Organic revenues advanced 1.5% to $678 million, while organic revenues with contingents increased 2.5% to $692 million.Net new business and exposure-unit expansion supported organic growth. These gains were partially offset by declines in catastrophe property rates and lower revenues from a specialty pharmacy business. Adjusted EBITDAC climbed 46.9% to $282 million, and the margin expanded 230 basis points to 29.8%. Specialty Distribution revenues increased 28.1% to $721 million, aided by acquisitions and higher contingent commissions. Organic revenues, however, declined 3.5% to $498 million, while organic revenues with contingents fell 1.6% to $545 million.Declining catastrophe property rates and approximately $10 million of new-business timing pressure weighed on the segment. Adjusted EBITDAC rose 17.1% to $308 million, but the adjusted margin contracted 400 basis points to 42.7% amid weaker organic revenues and investments in European capabilities. Total expenses increased 32.8% year over year to $1.29 billion. Employee compensation and benefits rose 31% to $838 million, while other operating expenses increased 28.4% to $271 million. Amortization more than doubled to $110 million, and interest expense increased 96% to $100 million. Adjusted EBITDAC rose 27% to $598 million, but growth trailed the top-line increase, resulting in margin contraction. Adjusted income before taxes increased 17.4% to $480 million. Net cash provided by operating activities increased 13% to $608 million during the first six months of 2026. Cash and cash equivalents were $918 million as of June 30, down from $1.08 billion at the end of 2025.The company repurchased $250 million of stock during the second quarter. Brown & Brown also paid $112 million in dividends and declared a quarterly dividend of 16.5 cents per share, up 10% year over year. Management expects rate changes across most admitted insurance lines in the second half of 2026 to remain relatively similar to second-quarter levels. Casualty and auto rates continued to increase, while property and workers’ compensation pricing was flat to lower.Excess-and-surplus casualty rates are expected to keep rising because of the legal environment. Brown & Brown does not expect catastrophe property rates to change materially in the second half compared with the first. Capital deployment will focus on share repurchases; internal investment, debt reduction and acquisitions centered on specialty businesses. In the past month, investors have witnessed a upward trend in estimates review. At this time, Brown & Brown has a subpar Growth Score of D, though it is lagging a bit on the Momentum Score front with an F. Charting a somewhat similar path, the stock was allocated a score of D on the value side, putting it in the bottom 40% for this investment strategy. Overall, the stock has an aggregate VGM Score of F. If you aren't focused on one strategy, this score is the one you should be interested in. Estimates have been trending upward for the stock, and the magnitude of these revisions looks promising. Notably, Brown & Brown has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Brown & Brown, Inc. (BRO) : Free Stock Analysis Report This article originally published on Zacks Investment Research (zacks.com). Zacks Investment Research

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Brown & Brown stock has delivered a 30.9% total return over the past five years, yet its valuation checks send mixed signals, with the Excess Returns intrinsic value estimate pointing to upside while earnings-based multiples screen the shares as expensive. That gap in views is sharpened by a weak 1 year share price result alongside a recent bounce. Over five years, Brown & Brown has returned 30.9%, which signals the stock has still created value for long term holders despite shorter term setbacks. The durability of Brown & Brown's insurance brokerage margins can support higher intrinsic value, while any pressure on cash flow quality or acquisition returns may weigh on how much investors are willing to pay. The broader valuation checks are mixed rather than decisive, with Brown & Brown passing 3 of 6 tests, which you can review in detail at 3 of 6 valuation checks. The issue now is whether Brown & Brown's current US$73.34 share price already reflects its long term cash generation or if the intrinsic value estimate still leaves a meaningful margin of safety for new capital. Find out why Brown & Brown's -22.9% return over the last year is lagging behind its peers. The Excess Returns model evaluates how efficiently Brown & Brown uses its equity base to generate profits above the required cost of capital. For Brown & Brown, the key inputs indicate a business generating returns that exceed what shareholders are assumed to require. Book Value is $38.13 per share and Stable EPS is $6.53 per share, based on the median return on equity from the past 5 years. Against a Cost of Equity of $3.04 per share, the model estimates an Excess Return of $3.50 per share, with an Average Return on Equity of 15.57%. That return profile is combined with a Stable Book Value of $41.95 per share, sourced from weighted future book value estimates from 2 analysts, to arrive at an intrinsic value estimate of $140.82 per share. Compared with the current share price of $73.34, the Excess Returns valuation suggests that Brown & Brown is trading at a 47.9% discount to its estimated intrinsic value. On this model, Brown & Brown stock appears undervalued relative to its estimated intrinsic value. Our Excess Returns analysis suggests Brown & Brown is undervalued by 47.9%. Track this in your watchlist or portfolio, or discover 49 more high quality undervalued stocks. Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for Brown & Brown. P/E suits Brown & Brown because earnings remain a key anchor for how investors typically value established insurance brokers. On this measure, Brown & Brown trades on a P/E of 20.6x, which is higher than the Insurance industry average of 11.2x and also above a peer group average of 34.5x. The peer figure reflects other companies whose earnings profiles influence how investors think about the sector as a whole. The tailored fair P/E ratio for Brown & Brown is 13.4x, based on its specific mix of growth assumptions, margins, size and risk inputs. The current 20.6x multiple sits well above this fair ratio, which indicates that investors are paying a premium price for each dollar of earnings compared with what this framework would suggest. This contrasts with the Excess Returns valuation, which points to potential upside on intrinsic value even though the earnings multiple screens the stock as expensive. On the P/E multiple alone, Brown & Brown stock currently screens as overvalued relative to the fair ratio implied by its fundamentals. See what the numbers say about this price — find out in our valuation breakdown. Simply Wall St Narratives for Brown & Brown pick up where this valuation puzzle leaves off by spelling out the specific paths for Brown & Brown's growth, margins and earnings that would make the stock worth materially more or less than today's price. Instead of giving a single figure, these scenarios show the future that each ratio or model relies on so you can monitor whether those assumptions continue to hold. They are available on Simply Wall St's Community page for Brown & Brown. You can add your voice to the Brown & Brown story by publishing a Narrative that lays out your number driven view on where its growth, margins and execution go from here. Share your case in the Simply Wall St community and see how it stacks up as new results and information emerge over time. Do you think there's more to the story for Brown & Brown? Head over to our Community to see what others are saying! Brown & Brown offers a split message. The intrinsic value estimate from the Excess Returns work suggests the stock is undervalued, while the earnings multiple points to an overvalued position on current pricing. That mismatch comes from a model that leans on long term cash generation and returns on equity, against a market that is focused on what investors are willing to pay for each dollar of earnings today. The key question from here is whether Brown & Brown can keep converting its equity base into strong, repeatable cash flows that justify both the intrinsic value case and the current premium P/E. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include BRO. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]

Looking back on insurance brokers stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including Brown & Brown (NYSE:BRO) and its peers. The insurance brokerage industry, while influenced by insurance pricing cycles, benefits from durable secular tailwinds as rising risk complexity (climate, data privacy), regulatory scrutiny, and insurance pricing inflation. These increase demand for professional risk-management advice. Brokers operate models that rely on commissions and fees tied to premium volumes and growing contributions from recurring advisory, benefits, and compliance services. Scale is a key advantage, enabling better carrier access, stronger data and benchmarking, and efficient deployment of technology and compliance investments, which in turn supports ongoing industry consolidation. The headwinds are labor intensity and wage inflation for producers, regulatory complexity (this cuts both ways, as you can see), and execution risk when integrating new digital tools into legacy workflows. The 5 insurance brokers stocks we track reported a satisfactory Q2. As a group, revenues beat analysts’ consensus estimates by 0.8%. In light of this news, share prices of the companies have held steady as they are up 2.1% on average since the latest earnings results. With roots dating back to 1939 and operations spanning 44 U.S. states and 14 countries, Brown & Brown (NYSE:BRO) is an insurance brokerage and risk management firm that markets and sells insurance products across property, casualty, and employee benefits sectors. Brown & Brown reported revenues of $1.68 billion, up 30.4% year on year. This print fell short of analysts’ expectations by 2.5%. Overall, it was a softer quarter for the company with EPS in line with analysts’ estimates. Brown & Brown scored the fastest revenue growth but had the weakest performance against analyst estimates among its peers. Unsurprisingly, the stock is up 2.7% since reporting and currently trades at $71.60. Is now the time to buy Brown & Brown? Access our full analysis of the earnings results here, it’s free. Founded in 2010 by insurance industry veteran Patrick Ryan, Ryan Specialty (NYSE:RYAN) is a wholesale insurance broker and underwriting manager that helps retail brokers place complex or hard-to-place risks with insurance carriers. Ryan Specialty reported revenues of $916.6 million, up 7.2% year on year, outperforming analysts’ expectations by 5.3%. The business had an incredible quarter with a beat of analysts’ EPS estimates. Ryan Specialty scored the biggest analyst estimate beat of the whole group. Although it had a fine quarter compared to its peers, the market seems unhappy with the results as the stock is down 4.5% since reporting. It currently trades at $42.13. Is now the time to buy Ryan Specialty? Access our full analysis of the earnings results here, it’s free. Founded in 1927 and operating in approximately 130 countries through direct operations and correspondent networks, Arthur J. Gallagher (NYSE:AJG) provides insurance brokerage, reinsurance, consulting, and third-party claims settlement services to businesses and individuals worldwide. Arthur J. Gallagher reported revenues of $4.00 billion, up 24.3% year on year, falling short of analysts’ expectations by 0.5%. It was a mixed quarter as it posted a narrow beat of analysts’ EPS estimates. The stock is flat since the results and currently trades at $254.50. Read our full analysis of Arthur J. Gallagher’s results here. With roots dating back to 1871 and a presence in over 130 countries, Marsh (NYSE:MRSH) is a global professional services firm that helps organizations manage risk, strategy, and workforce challenges through its four specialized businesses. Marsh reported revenues of $7.40 billion, up 6.2% year on year. This print beat analysts’ expectations by 1.8%. Overall, it was a strong quarter as it also logged a solid beat of analysts’ organic revenue estimates and a beat of analysts’ EPS estimates. Marsh had the slowest revenue growth in the group. The stock is up 5% since reporting and currently trades at $191.27. Read our full, actionable report on Marsh here, it’s free. Rebranded from BRP Group in May 2024, Baldwin Insurance Group (NASDAQ:BWIN) is an independent insurance distribution company that provides tailored insurance, risk management, and employee benefits solutions to businesses and individuals. Baldwin Insurance Group reported revenues of $492.9 million, up 30.1% year on year. This number met analysts’ expectations. Taking a step back, it was a mixed quarter as it also recorded EPS in line with analysts’ estimates but a miss of analysts’ organic revenue estimates. The stock is up 8% since reporting and currently trades at $28.83. Read our full, actionable report on Baldwin Insurance Group here, it’s free. Over the past year, investors have been forced to repeatedly answer the same question: what is the market’s biggest risk? The answer has changed several times, and each shift has reshaped market leadership. Late in 2025 and early 2026, artificial intelligence became the market’s primary uncertainty. Investors questioned whether AI would erode software pricing power and weaken competitive moats as AI made it easier to replicate once-differentiated products. By the spring, technology took a back seat to geopolitics. The U.S. conflict with Iran briefly became the market’s dominant narrative, raising concerns about oil prices, inflation, and global growth. But as energy markets remained orderly and fears of a prolonged supply disruption faded, investors quickly turned their focus back to fundamentals. Want to invest in winners with rock-solid fundamentals? Check out our Hidden Gem Stocks and add them to your watchlist. These companies are poised for growth regardless of the political or macroeconomic climate.

Brown & Brown’s second quarter results for 2026 fell short of market revenue expectations, but sales still rose 30.4% year on year to $1.68 billion. Management attributed performance to strong contingent commissions, effective integration of acquisitions, and ongoing enhancements to its sales and underwriting processes. CEO J. Powell Brown emphasized, “Our enhanced go-to-market sales model is building momentum with newly aligned teams collaborating, developing opportunities, and generating incremental new business wins.” The company also noted progress in controlling expenses, even as operating margin declined year-over-year, and highlighted solid cash flow generation and share repurchases as additional contributors to the quarter’s outcomes. Is now the time to buy BRO? Find out in our full research report (it’s free). Revenue: $1.68 billion vs analyst estimates of $1.72 billion (30.4% year-on-year growth, 2.5% miss) Adjusted EPS: $1.07 vs analyst estimates of $1.07 (in line) Adjusted EBITDA: $611 million vs analyst estimates of $603.1 million (36.5% margin, 1.3% beat) Operating Margin: 22.9%, down from 24.2% in the same quarter last year Market Capitalization: $23.56 billion While we enjoy listening to the management’s commentary, our favorite part of earnings calls is the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention. Michael Zaremski (BMO Capital Markets) asked about the timing and sustainability of Accession’s revenue and margin contributions. CFO R. Watts clarified that revenue seasonality is expected and margins should remain stable, with earnout-related cash flow impacts being one-time in nature. Charles Peters (Raymond James) questioned the impact of increased competition from managing general agents (MGAs) on specialty distribution growth. CEO J. Powell Brown acknowledged pricing pressure but stressed disciplined underwriting and a broader, more balanced risk portfolio. Elyse Greenspan (Wells Fargo) asked about hiring activity and its impact on organic growth. Brown explained that ongoing hiring is part of standard operations and that any substantial investments in new talent would be explicitly disclosed. Robert Cox (Goldman Sachs) inquired about margin guidance and the absorption of AI-related costs. Watts reiterated that technology investments are being offset by cost reallocation, and synergy targets remain unchanged, with no current plans for additional tech spending. Taylor Scott (Barclays) asked about expansion efforts in Europe. Brown detailed investments in hiring and capabilities for wholesale and programs businesses, citing London as a focus area for future organic growth. In the coming quarters, the StockStory team will be monitoring (1) the pace and impact of AI adoption across sales and underwriting workflows, (2) realization of cost synergies and integration benefits from the Accession acquisition, and (3) trends in contingent commissions and organic growth as insurance market competition intensifies. The effectiveness of capital allocation between share repurchases, technology investment, and future M&A will also be important for long-term performance. Brown & Brown currently trades at $70.40, up from $69.70 just before the earnings. In the wake of this quarter, is it a buy or sell? See for yourself in our full research report (it’s free for active Edge members). ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren’t just high-quality businesses. Something is happening with them right now. Elite fundamentals meet near-term momentum — both boxes checked at the same time. Find out which stocks our AI platform is flagging this week. See this week’s Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE. Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+214% between June 2020 and June 2025). Find your next big winner with StockStory today.

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Brown & Brown (BRO) drew fresh investor attention after reporting second quarter 2026 results, with revenue of US$1.676b and net income of US$288m, alongside updated buyback and dividend activity. See our latest analysis for Brown & Brown. Despite the latest share price of US$70.40 and a 22.16% 90 day share price return that hints at improving momentum, Brown & Brown's year to date share price return is down 9.30% and its 1 year total shareholder return is down 23.00%. This contrasts with the modestly positive 3 year and 5 year total shareholder returns of 2.72% and 33.83%. If Brown & Brown's recent results have you reassessing your watchlist, this can be a good moment to broaden your search and check out 18 top founder-led companies The recent swing in Brown & Brown's share price sits against a wide range of value estimates, from intrinsic models to analyst targets. With the stock still below those reference points, how wide is the gap to fair value now? Brown & Brown's most followed valuation narrative points to a fair value of $75.63, which sits above the latest close at $70.40 and frames the recent pullback against a modest valuation gap. Read the complete narrative. The fair value story for Brown & Brown rests on a specific mix of projected revenue growth, shifts in profit margins, and a richer future earnings multiple. If you are curious which assumptions really carry the weight, the full narrative spells out the numbers behind that earnings path and the valuation gap. Result: Fair Value of $75.63 (UNDERVALUED) Have a read of the narrative in full and understand what's behind the forecasts. However, Brown & Brown's story still carries pressure points, including rising pharmacy costs in benefits and potential legislative shifts in Florida that could squeeze margins and weaken this valuation case. Find out about the key risks to this Brown & Brown narrative. The earlier fair value narrative for Brown & Brown leaned on long term earnings forecasts and price targets. The P/E picture tells a less forgiving story. At 19.8x earnings, Brown & Brown trades well above the US Insurance industry at 12.1x and also above its own fair ratio of 12.5x, which points to valuation risk if sentiment cools. For investors weighing these mixed signals, the key question is which set of assumptions feels more realistic for the next few years: the upside case from earnings models, or the warning coming from today’s richer multiple, and how much room that leaves for error. See what the numbers say about this price — find out in our valuation breakdown. Seeing mixed takeaways in Brown & Brown's story so far is understandable, so use the data, valuation work, and sentiment signals to pressure test your own view, then round it out by checking 3 key rewards and 2 important warning signs If Brown & Brown's latest update has sharpened your focus, do not stop here. Use this momentum to hunt for other opportunities before they move out of reach. Spot potential bargains by scanning companies that look mispriced on quality and value using the 55 high quality undervalued stocks. Build a steadier income stream by reviewing companies in the 9 dividend fortresses that combine payout strength with resilience. Reduce portfolio shocks by focusing on businesses screened in the 81 resilient stocks with low risk scores that show lower risk profiles. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include BRO. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]